Replies to post #32072 on Ocata Therapeutics Inc fka OCAT

[rumit]

Well said Rocky,

If anything was to be recognized(as new) from e-mail exchange I had, I felt it was the fact that OHSU is seeking IRB approval and dealing with contract to become a trial site for dryAMD.

This was the key takeaway, and is great news for ACT. The fact that your post could be construed as negative is beyond me.